Propericiazin, diazepam, chlorpromazine and placebo in a doubleblind trial in pedopsychiatric therapy.
D000293:Adolescent; D000374:Aggression / Q000187:drug effects; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D002746:Chlorpromazine / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D009043:Motor Activity / Q000187:drug effects; D009570:Nitriles / Q000627:therapeutic use*; D010640:Phenothiazines / Q000494:pharmacology / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D009570:Nitriles; D010640:Phenothiazines; D010880:Piperidines; D010919:Placebos; D014149:Tranquilizing Agents; D003975:Diazepam; D002746:Chlorpromazine